Publications of Stephan Ripke
All genres
Journal Article (34)
1.
Journal Article
45 (9), pp. 984 - 994 (2013)
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. NATURE GENETICS 2.
Journal Article
23 (7), pp. 653 - 662 (2013)
Resistance to antidepressant treatment is associated with polymorphisms in the leptin gene, decreased leptin mRNA expression, and decreased leptin serum levels. EUROPEAN NEUROPSYCHOPHARMACOLOGY 3.
Journal Article
43 (10), pp. 977 - 983 (2011)
Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nature Genetics 4.
Journal Article
16 (6), pp. 647 - 663 (2011)
TMEM132D, a new candidate for anxiety phenotypes: evidence from human and mouse studies. Molecular Psychiatry 5.
Journal Article
70, pp. 252 - 265 (2011)
The neuronal transporter gene SLC6A15 confers risk to major depression. Neuron 6.
Journal Article
15 (7), pp. 736 - 747 (2010)
Variations in tryptophan hydroxylase 2 linked to decreased serotonergic activity are associated with elevated risk for metabolic syndrome in depression. Molecular Psychiatry 7.
Journal Article
150B (8), pp. 1100 - 1109 (2009)
Polymorphisms in the GAD2 Gene-Region Are Associated With Susceptibility for Unipolar Depression and With a Risk Factor for Anxiety Disorders. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 8.
Journal Article
73, pp. 665 - 666 (2009)
Pharmacogenetics of antidepressant treatment outcome - Results from a genome-wide multilocus analysis including clinical predictors. Annals of Human Genetics 9.
Journal Article
66 (9), pp. 966 - 975 (2009)
A Genomewide Association Study Points to Multiple Loci That Predict Antidepressant Drug Treatment Outcome in Depression. Archives of General Psychiatry 10.
Journal Article
42 (5), p. 224 - 224 (2009)
A genome-wide association study points to multiple loci predicting antidepressant treatment outcome in depression. Pharmacopsychiatry 11.
Journal Article
42 (5), p. 226 - 226 (2009)
Polymorphisms in tryptophan hydroxylase 2 leading to decreased serotonergic activity contribute to elevated risk for metabolic syndrome in depression. Pharmacopsychiatry 12.
Journal Article
42 (5), p. 230 - 230 (2009)
The neuronal transporter gene SLC6A15 confers risk to major depression. Pharmacopsychiatry 13.
Journal Article
42 (5), p. 244 - 244 (2009)
Polymorphisms in the gene encoding the neuropeptide galanin are associated with HPA-axis dysregulation and symptome severity in major-depressive- and anxiety-disorder patients. Pharmacopsychiatry 14.
Journal Article
104 (7), pp. 1737 - 1744 (2009)
Novel Genetic Risk Markers for Ulcerative Colitis in the IL2/IL21 Region Are in Epistasis With IL23R and Suggest a Common Genetic Background for Ulcerative Colitis and Celiac Disease. American Journal of Gastroenterology 15.
Journal Article
116 (6), pp. 649 - 657 (2009)
The GABA transporter 1 (SLC6A1): a novel candidate gene for anxiety disorders. Journal of Neural Transmission 16.
Journal Article
40 (3), pp. 970 - 972 (2009)
Genetic Variation in the Lymphotoxin-Alpha Pathway and the Risk of Ischemic Stroke in European Populations. Stroke 17.
Journal Article
150B (1), pp. 104 - 114 (2009)
Polymorphisms in the Angiotensin-Converting Enzyme Gene Region Predict Coping Styles in Healthy Adults and Depressed Patients. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 18.
Journal Article
13 (9), pp. 831 - 832 (2008)
Evidence for associations between PDE4D polymorphisms and a subtype of neuroticism. Molecular Psychiatry 19.
Journal Article
40 (8), pp. 946 - 948 (2008)
PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome. Nature Genetics 20.
Journal Article
11 (Suppl. 1), pp. 112 - 113 (2008)
Association of GRIK4 and 5-HTR2A with antidepressant treatment in the MARS cohort of depressed impatients. International Journal of Neuropsychopharmacology